Long-term, regular aspirin use was associated with reduced risk of death from several different kinds of cancers, according to data presented here at the AACR Annual Meeting 2017, April 1-5.

“Accumulating evidence suggests that aspirin not only reduces the risk of developing cancer, but may also play a strong role in reducing death from cancer,” said the study’s lead author, Yin Cao, MPH, ScD, an instructor in Medicine, Clinical and Translational Epidemiology Unit, at Massachusetts General Hospital and Harvard Medical School.

Link to full American Association of Cancer Research release.